Loading...

Emmanuelle Waubant, MD, PhD

Title(s)Professor, Neurology
SchoolSchool of Medicine
Address675 Nelson Rising Lane
San Francisco CA 94158
Phone415-514-8199
vCardDownload vCard
    Other Positions
    Title(s)UCSF Weill Institute for Neurosciences


    Collapse Biography 
    Collapse Awards and Honors
    Best Doctors in America2010Selected one of the "Best Doctors in America"
    UCSF2010Nominated for the Chancellor's Award for the Advancement of Women
    American Academy of Neurology2010Fellow of the American Academy of Neurology
    UCSF2010Nominated for the Outstanding Faculty Mentorship Award
    UCSF2008Nominated for the Outstanding Faculty Mentorship Award
    UCSF2011 Nominated for the Outstanding Faculty Mentorship Award
    UCSF2012 Nominated for the Outstanding Faculty Mentorship Award
    UCSF2013 Nominated for the Outstanding Faculty Mentorship Award
    American Neurological Association2013Fellow of the American Neurological Association

    Collapse Overview 
    Collapse Overview
    Dr Waubant trained as a neurologist in Toulouse, France. She continued her training as a neuroimmunology fellow in Dr Stephen Hauser’s UCSF laboratory, focusing on matrix metalloproteinases (MMP) and their tissue inhibitors (TIMP), and their role in migration of lymphocytes through equivalents of the blood-brain barrier. In 1994, Dr Waubant returned to Toulouse to complete her 2-year junior faculty/chief residency in neurology. Dr Waubant later returned as a clinical research fellow at the UCSF MS Center with Dr Donald Goodkin. During that 3-year period, she furthered her in vitro MMP work to the study in the human disease that helped to understand the role of MMP-9 and TIMP-1 in patients with MS and their relationship to disease activity. After completing her clinical research training at the UCSF MS center, Dr Waubant returned to France to lead a clinical research center at Salpetriere Hospital in Paris for 2 years. She returned to the UCSF MS center in September 2001 as a faculty. She is also the Race to Erase MS Medical Director and coordinates clinical research collaborations between 6 American MS Centers of Excellence. With the support of the National MS Society, she has started a regional pediatric MS clinic at UCSF in January 2006 that she directs and has since seen over 350 patients with pediatric MS or related disorders. She is the editor of the first text book on Pediatric MS and related disorders. Dr Waubant is At-large Board Director and on the program committee of the the American Committee on Treatment and Research in MS and the Chair of the U.S. Pediatric MS Steering Committee. She is also chairing the international Clinical Trial Task Force for pediatric MS.
    Dr Waubant’s specific interests include the translation of promising agents from the bench to the bedside, understanding factors that predict the response to MS therapies, and risk factors for pediatric MS susceptibility and disease modification. Currently, she is the co-lead investigator for a trial of vitamin D in relapsing-remitting MS sponsored by the NMSS and is the recipient of a large multicenter NIH grant to study risk factors in pediatric MS and their interactions. Dr. Waubant is also a very active mentor for junior investigators.

    Collapse Research 
    Collapse Research Activities and Funding
    Environmental and genetic risk factors for pediatric MS
    NIH/NINDS R01NS071463Aug 15, 2010 - Apr 30, 2016
    Role: Principal Investigator

    Collapse ORNG Applications 
    Collapse Clinical Trials
    Collapse Featured Publications
    Collapse Websites
    Collapse In The News
    Collapse Faculty Mentoring
    Collapse Academic Senate

    Collapse Bibliographic 
    Collapse Publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help. to make corrections and additions.
    Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
    Altmetrics Details PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Improved relapse recovery in paediatric compared to adult multiple sclerosis. Brain. 2020 Aug 18. Chitnis T, Aaen G, Belman A, Benson L, Gorman M, Goyal MS, Graves JS, Harris Y, Krupp L, Lotze T, Mar S, Ness J, Rensel M, Schreiner T, Tillema JM, Waubant E, Weinstock-Guttman B, Roalstad S, Rose J, Weiner HL, Casper TC, Rodriguez M. PMID: 32810215.
      View in: PubMed   Mentions:    Fields:    
    2. Pediatric Multiple Sclerosis Severity Score in a large US cohort. Neurology. 2020 Sep 29; 95(13):e1844-e1853. Santoro JD, Waltz M, Aaen G, Belman A, Benson L, Gorman M, Goyal MS, Graves JS, Harris Y, Krupp L, Lotze T, Mar S, Moodley M, Ness J, Rensel M, Rodriguez M, Schreiner T, Tillema JM, Waubant E, Weinstock-Guttman B, Hurtubise BF, Roalstad S, Rose J, Casper TC, Chitnis T. PMID: 32690790.
      View in: PubMed   Mentions:    Fields:    
    3. A validation study for remote testing of cognitive function in multiple sclerosis. Mult Scler. 2020 Jul 14; 1352458520937385. Barcellos LF, Horton M, Shao X, Bellesis KH, Chinn T, Waubant E, Bakshi N, Marcus J, Benedict RH, Schaefer C. PMID: 32662747.
      View in: PubMed   Mentions:    Fields:    
    4. Ocrelizumab exposure in the second trimester of pregnancy without neonatal B-cell depletion. Mult Scler Relat Disord. 2020 Jul 14; 45:102398. Rolfes M, Rutatangwa A, Waubant E, Krysko KM. PMID: 32707531.
      View in: PubMed   Mentions:    Fields:    
    5. Two-armed active comparator trials are unethical in paediatric multiple sclerosis - Commentary. Mult Scler. 2020 Jul 10; 1352458520936243. Waubant E. PMID: 32648815.
      View in: PubMed   Mentions:    Fields:    
    6. Temporal profile of lymphocyte counts and relationship with infections with fingolimod therapy in paediatric patients with multiple sclerosis: Results from the PARADIGMS study. Mult Scler. 2020 Jul 07; 1352458520936934. Chitnis T, Banwell B, Krupp L, Arnold DL, Bar-Or A, Brück W, Giovannoni G, Greenberg B, Ghezzi A, Waubant E, Rostasy K, Deiva K, Huppke P, Wolinsky JS, Zhang Y, Azmon A, K-Laflamme A, Karan R, Gärtner J. PMID: 32633694.
      View in: PubMed   Mentions:    Fields:    
    7. Bile acid metabolism is altered in multiple sclerosis and supplementation ameliorates neuroinflammation. J Clin Invest. 2020 Jul 01; 130(7):3467-3482. Bhargava P, Smith MD, Mische L, Harrington E, Fitzgerald KC, Martin K, Kim S, Reyes AA, Gonzalez-Cardona J, Volsko C, Tripathi A, Singh S, Varanasi K, Lord HN, Meyers K, Taylor M, Gharagozloo M, Sotirchos ES, Nourbakhsh B, Dutta R, Mowry EM, Waubant E, Calabresi PA. PMID: 32182223.
      View in: PubMed   Mentions: 1     Fields:    
    8. Dare we mention the C-word? Mult Scler Relat Disord. 2020 Aug; 43:102340. Giovannoni G, Hawkes CH, Lechner-Scott J, Levy M, Waubant E. PMID: 32660744.
      View in: PubMed   Mentions:    Fields:    
    9. Rituximab in patients with pediatric multiple sclerosis and other demyelinating disorders of the CNS: Practical considerations. Mult Scler. 2020 Jun 19; 1352458520932798. Ghezzi A, Banwell B, Bar-Or A, Chitnis T, Dale RC, Gorman M, Kornek B, Krupp L, Krysko KM, Nosadini M, Rostasy K, Salzer J, Schreiner T, Tenembaum S, Waubant E. PMID: 32552353.
      View in: PubMed   Mentions:    Fields:    
    10. Do you believe in Gad? Mult Scler Relat Disord. 2020 Jun 11; 44:102299. Maghzi AH, Sicotte NL, Waubant E. PMID: 32593143.
      View in: PubMed   Mentions:    Fields:    
    11. Changes in patient and physician attitudes resulting from COVID-19 in neuromyelitis optica spectrum disorder and multiple sclerosis. Mult Scler Relat Disord. 2020 07; 42:102259. Salama S, Giovannoni G, Hawkes CH, Lechner-Scott J, Waubant E, Levy M. PMID: 32571580.
      View in: PubMed   Mentions:    Fields:    Translation:HumansCellsPHPublic Health
    12. Autoimmune Encephalitis in Children: A Case Series at a Tertiary Care Center. J Child Neurol. 2020 Aug; 35(9):591-599. Rutatangwa A, Mittal N, Francisco C, Nash K, Waubant E. PMID: 32458722.
      View in: PubMed   Mentions:    Fields:    
    13. Real-World Effectiveness of Initial Disease-Modifying Therapies in Pediatric Multiple Sclerosis. Ann Neurol. 2020 Jul; 88(1):42-55. Krysko KM, Graves JS, Rensel M, Weinstock-Guttman B, Rutatangwa A, Aaen G, Belman A, Benson L, Chitnis T, Gorman M, Goyal MS, Harris Y, Krupp L, Lotze T, Mar S, Moodley M, Ness J, Rodriguez M, Rose J, Schreiner T, Tillema JM, Waltz M, Casper TC, Waubant E. PMID: 32267005.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    14. Is multiple sclerosis a risk factor for infections? Mult Scler Relat Disord. 2020 Jun; 41:102184. Lechner-Scott J, Waubant E, Levy M, Hawkes C, Giovannoni G. PMID: 32571610.
      View in: PubMed   Mentions:    Fields:    
    15. The future of microbiome research in neuroinflammatory disorders. Mult Scler Relat Disord. 2020 May; 40:102098. Waubant E, Pröbstel AK, Levy M, Hawkes CH, Giovannoni G, Lechner-Scott J, Tremlett H. PMID: 32312515.
      View in: PubMed   Mentions:    Fields:    
    16. The COVID-19 pandemic and the use of MS disease-modifying therapies. Mult Scler Relat Disord. 2020 04; 39:102073. Giovannoni G, Hawkes C, Lechner-Scott J, Levy M, Waubant E, Gold J. PMID: 32334820.
      View in: PubMed   Mentions: 28     Fields:    Translation:HumansCellsPHPublic Health
    17. Big pharma and social responsibility. Mult Scler Relat Disord. 2020 Apr; 39:102069. Hawkes CH, Giovannoni G, Levy M, Lechner-Scott J, Waubant E. PMID: 32334821.
      View in: PubMed   Mentions:    Fields:    
    18. Effect of fingolimod on MRI outcomes in patients with paediatric-onset multiple sclerosis: results from the phase 3 PARADIGMS study. J Neurol Neurosurg Psychiatry. 2020 May; 91(5):483-492. Arnold DL, Banwell B, Bar-Or A, Ghezzi A, Greenberg BM, Waubant E, Giovannoni G, Wolinsky JS, Gärtner J, Rostásy K, Krupp L, Tardieu M, Brück W, Stites TE, Pearce GL, Häring DA, Merschhemke M, Chitnis T. PMID: 32132224.
      View in: PubMed   Mentions:    Fields:    
    19. Ageing and multiple sclerosis. Mult Scler Relat Disord. 2020 02; 38:101953. Giovannoni G, Hawkes CH, Lechner-Scott J, Levy M, Waubant E. PMID: 32164909.
      View in: PubMed   Mentions:    Fields:    
    20. Association Between Breastfeeding and Postpartum Multiple Sclerosis Relapses: A Systematic Review and Meta-analysis. JAMA Neurol. 2019 Dec 09. Krysko KM, Rutatangwa A, Graves J, Lazar A, Waubant E. PMID: 31816024.
      View in: PubMed   Mentions: 2     Fields:    
    21. "Is this new medicine going to help me walk again?" Mult Scler Relat Disord. 2020 01; 37:101875. Levy M, Waubant E, Hawkes C, Giovannoni G, Lechner-Scott J. PMID: 32172990.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    22. Cognitive processing speed in pediatric-onset multiple sclerosis: Baseline characteristics of impairment and prediction of decline. Mult Scler. 2019 Nov 28; 1352458519891984. Wallach AI, Waltz M, Casper TC, Aaen G, Belman A, Benson L, Chitnis T, Gorman M, Graves J, Harris Y, Lotze TE, Mar S, Moodley M, Ness JM, Rensel M, Rodriguez M, Rose JW, Schreiner T, Tillema JM, Waubant E, Weinstock-Guttman B, Charvet LE, Krupp LB. PMID: 31775571.
      View in: PubMed   Mentions:    Fields:    
    23. Silent symptoms of multiple sclerosis. Mult Scler Relat Disord. 2019 11; 36:101453. Lechner-Scott J, Waubant E, Levy M, Hawkes C. PMID: 31812240.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    24. The multiple sclerosis gut microbiota: A systematic review. Mult Scler Relat Disord. 2020 Jan; 37:101427. Mirza A, Forbes JD, Zhu F, Bernstein CN, Van Domselaar G, Graham M, Waubant E, Tremlett H. PMID: 32172998.
      View in: PubMed   Mentions: 3     Fields:    
    25. Grassroot efforts towards diversity in MS care and research: Win-win for patients and science. Mult Scler Relat Disord. 2019 10; 35:A1-A2. Waubant E, Levy M, Lechner-Scott J, Giovannoni G, Hawkes C. PMID: 31679745.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    26. Clinical Features and Outcomes of Pediatric Monophasic and Recurrent Idiopathic Optic Neuritis. J Child Neurol. 2020 01; 35(1):77-83. Jonzzon S, Suleiman L, Yousef A, Young B, Hart J, Peschl P, Reindl M, Schaller KL, Bennett JL, Waubant E, Graves JS. PMID: 31566057.
      View in: PubMed   Mentions:    Fields:    
    27. Seafood, fatty acid biosynthesis genes, and multiple sclerosis susceptibility. Mult Scler. 2020 Oct; 26(12):1476-1485. Langer-Gould A, Black LJ, Waubant E, Smith JB, Wu J, Gonzales EG, Shao X, Koebnick C, Lucas RM, Xiang A, Barcellos LF. PMID: 33063621.
      View in: PubMed   Mentions:    Fields:    
    28. Consistent control of disease activity with fingolimod versus IFN ß-1a in paediatric-onset multiple sclerosis: further insights from PARADIGMS. J Neurol Neurosurg Psychiatry. 2020 01; 91(1):58-66. Deiva K, Huppke P, Banwell B, Chitnis T, Gärtner J, Krupp L, Waubant E, Stites T, Pearce GL, Merschhemke M. PMID: 31467033.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    29. Environmental and genetic risk factors for MS: an integrated review. Ann Clin Transl Neurol. 2019 09; 6(9):1905-1922. Waubant E, Lucas R, Mowry E, Graves J, Olsson T, Alfredsson L, Langer-Gould A. PMID: 31392849.
      View in: PubMed   Mentions: 8     Fields:    Translation:HumansPHPublic Health
    30. Multiple sclerosis and migration revisited. Mult Scler Relat Disord. 2019 09; 34:A1-A2. Hawkes CH, Giovannoni G, Lechner-Scott J, Levy M, Waubant E. PMID: 31543261.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    31. Implementing the 2017 McDonald criteria for the diagnosis of multiple sclerosis. Nat Rev Neurol. 2019 08; 15(8):441-445. Zipp F, Oh J, Fragoso YD, Waubant E. PMID: 31086264.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    32. A retrospective cohort study of plasma exchange in central nervous system demyelinating events in children. Mult Scler Relat Disord. 2019 Oct; 35:50-54. Manguinao M, Krysko KM, Maddike S, Rutatangwa A, Francisco C, Hart J, Chong J, Graves JS, Waubant E. PMID: 31319355.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    33. Editorial on: Eculizumab in aquaporin-4-positive neuromyelitis optica spectrum disorder. Mult Scler Relat Disord. 2019 08; 33:A1-A2. Pardo S, Giovannoni G, Hawkes C, Lechner-Scott J, Waubant E, Levy M. PMID: 31324299.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    34. Introducing the International Women in Multiple Sclerosis network. Lancet Neurol. 2019 06; 18(6):521. Jokubaitis VG, Pröbstel AK, Arrambide G, Costello F, Waubant E. PMID: 31122489.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    35. miRNA contributions to pediatric-onset multiple sclerosis inferred from GWAS. Ann Clin Transl Neurol. 2019 Jun; 6(6):1053-1061. Rhead B, Shao X, Graves JS, Chitnis T, Waldman AT, Lotze T, Schreiner T, Belman A, Krupp L, Greenberg BM, Weinstock-Guttman B, Aaen G, Tillema JM, Rodriguez M, Hart J, Caillier S, Ness J, Harris Y, Rubin J, Candee MS, Gorman M, Benson L, Mar S, Kahn I, Rose J, Casper TC, Quach H, Quach D, Schaefer C, Waubant E, Barcellos LF. PMID: 31211169.
      View in: PubMed   Mentions:    Fields:    Translation:HumansCells
    36. Vitamin D genes influence MS relapses in children. Mult Scler. 2020 Jul; 26(8):894-901. Graves JS, Barcellos LF, Krupp L, Belman A, Shao X, Quach H, Hart J, Chitnis T, Weinstock-Guttman B, Aaen G, Benson L, Gorman M, Greenberg B, Lotze T, Soe M, Ness J, Rodriguez M, Rose J, Schreiner T, Tillema JM, Waldman A, Casper TC, Waubant E. PMID: 31081484.
      View in: PubMed   Mentions: 3     Fields:    
    37. Three suggestions to decrease the financial burden of MS treatments. Mult Scler Relat Disord. 2019 May; 30:A1. Waubant E, Giovannoni G, Hawkes C, Lechner-Scott J, Levy M. PMID: 30987755.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    38. Clinical trials of disease-modifying agents in pediatric MS: Opportunities, challenges, and recommendations from the IPMSSG. Neurology. 2019 05 28; 92(22):e2538-e2549. Waubant E, Banwell B, Wassmer E, Sormani MP, Amato MP, Hintzen R, Krupp L, Rostásy K, Tenembaum S, Chitnis T. PMID: 31043474.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    39. One size doesn't fit all. Mult Scler Relat Disord. 2019 06; 31:A1-A2. Lechner-Scott J, Giovannoni G, Hawkes C, Levy M, Waubant E. PMID: 31159999.
      View in: PubMed   Mentions:    Fields:    
    40. Acute flaccid myelitis in the 21st century: reminiscence of poliomyelitis or a new emergent disease. Mult Scler Relat Disord. 2019 Apr; 29:A1-A2. Levy M, Giovannoni G, Hawkes C, Lechner-Scott J, Waubant E. PMID: 30885376.
      View in: PubMed   Mentions:    Fields:    Translation:HumansCells
    41. Mind the gap: Quantifying gender representation as a first step to solve the problem? Neurology. 2019 04 09; 92(15):698-699. Waubant E, Gilmore W. PMID: 30894445.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    42. Multiple Sclerosis and Vitamin D - Caviar or a Dog's Dinner? Mult Scler Relat Disord. 2019 Feb; 28:A1-A2. Hawkes C, Giovannoni G, Lechner-Scott J, Levy M, Waubant E. PMID: 30823982.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    43. Admixture mapping reveals evidence of differential multiple sclerosis risk by genetic ancestry. PLoS Genet. 2019 01; 15(1):e1007808. Chi C, Shao X, Rhead B, Gonzales E, Smith JB, Xiang AH, Graves J, Waldman A, Lotze T, Schreiner T, Weinstock-Guttman B, Aaen G, Tillema JM, Ness J, Candee M, Krupp L, Gorman M, Benson L, Chitnis T, Mar S, Belman A, Casper TC, Rose J, Moodley M, Rensel M, Rodriguez M, Greenberg B, Kahn L, Rubin J, Schaefer C, Waubant E, Langer-Gould A, Barcellos LF. PMID: 30653506.
      View in: PubMed   Mentions: 7     Fields:    Translation:Humans
    44. Should our treatment target in MS include the intrathecal plasma cell response? Mult Scler Relat Disord. 2019 01; 27:A1-A2. Giovannoni G, Hawkes C, Levy M, Lechner-Scott J, Waubant E. PMID: 30642567.
      View in: PubMed   Mentions:    Fields:    Translation:HumansCells
    45. Acquisition of Early Developmental Milestones and Need for Special Education Services in Pediatric Multiple Sclerosis. J Child Neurol. 2019 03; 34(3):148-152. Aaen G, Waltz M, Vargas W, Makhani N, Ness J, Harris Y, Casper TC, Benson L, Candee M, Chitnis T, Gorman M, Graves J, Greenberg B, Lotze T, Mar S, Tillema JM, Rensel M, Rodriguez M, Rose J, Rubin J, Schreiner T, Waldman A, Weinstock-Guttman B, Belman A, Waubant E, Krupp L. PMID: 30556452.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    46. Pediatric glial fibrillary acidic protein meningoencephalomyelitis: A case report and review of the literature. Mult Scler Relat Disord. 2019 Apr; 29:148-152. Francisco C, Meddles K, Waubant E. PMID: 30885369.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    47. Subclinical Saccadic Eye Movement Dysfunction in Pediatric Multiple Sclerosis. J Child Neurol. 2019 01; 34(1):38-43. Yousef A, Devereux M, Gourraud PA, Jonzzon S, Suleiman L, Waubant E, Green A, Graves JS. PMID: 30463467.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    48. Body mass index, but not vitamin D status, is associated with brain volume change in MS. Neurology. 2018 12 11; 91(24):e2256-e2264. Mowry EM, Azevedo CJ, McCulloch CE, Okuda DT, Lincoln RR, Waubant E, Hauser SL, Pelletier D. PMID: 30429274.
      View in: PubMed   Mentions: 9     Fields:    Translation:Humans
    49. Vaccines and disease-modifying treatments. Mult Scler Relat Disord. 2018 11; 26:A1-A2. Waubant E, Giovannoni G, Hawkes C, Levy M. PMID: 30573174.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    50. Puberty onset and pediatric multiple sclerosis activity in boys. Mult Scler Relat Disord. 2019 Jan; 27:184-187. Young B, Waubant E, Lulu S, Graves J. PMID: 30390578.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    51. Use of newer disease-modifying therapies in pediatric multiple sclerosis in the US. Neurology. 2018 11 06; 91(19):e1778-e1787. Krysko KM, Graves J, Rensel M, Weinstock-Guttman B, Aaen G, Benson L, Chitnis T, Gorman M, Goyal M, Krupp L, Lotze T, Mar S, Rodriguez M, Rose J, Waltz M, Charles Casper T, Waubant E. PMID: 30333163.
      View in: PubMed   Mentions: 5     Fields:    Translation:Humans
    52. Several household chemical exposures are associated with pediatric-onset multiple sclerosis. Ann Clin Transl Neurol. 2018 Dec; 5(12):1513-1521. Mar S, Liang S, Waltz M, Casper TC, Goyal M, Greenberg B, Weinstock-Guttman B, Rodriguez M, Aaen G, Belman A, Barcellos LF, Rose J, Gorman M, Benson L, Candee M, Chitnis T, Harris Y, Kahn I, Roalsted S, Hart J, Lotze T, Moodley M, Ness J, Rensel M, Rubin J, Schreiner T, Tillema JM, Waldman A, Krupp L, Graves JS, Waubant E. PMID: 30564618.
      View in: PubMed   Mentions: 1     Fields:    
    53. Detection of HHV-6 and EBV and Cytokine Levels in Saliva From Children With Seizures: Results of a Multi-Center Cross-Sectional Study. Front Neurol. 2018; 9:834. Bartolini L, Piras E, Sullivan K, Gillen S, Bumbut A, Lin CM, Leibovitch EC, Graves JS, Waubant EL, Chamberlain JM, Gaillard WD, Jacobson S. PMID: 30344507.
      View in: PubMed   Mentions:
    54. Refining the Nosology of Antigen-Specific Diseases Within the Spectrum of Neuromyelitis Optica. Mult Scler Relat Disord. 2018 10; 25:A1-A2. Levy M, Giovannoni G, Hawkes C, Waubant E. PMID: 30384960.
      View in: PubMed   Mentions:    Fields:    
    55. Urban air quality and associations with pediatric multiple sclerosis. Ann Clin Transl Neurol. 2018 Oct; 5(10):1146-1153. Lavery AM, Waubant E, Casper TC, Roalstad S, Candee M, Rose J, Belman A, Weinstock-Guttman B, Aaen G, Tillema JM, Rodriguez M, Ness J, Harris Y, Graves J, Krupp L, Charvet L, Benson L, Gorman M, Moodley M, Rensel M, Goyal M, Mar S, Chitnis T, Schreiner T, Lotze T, Greenberg B, Kahn I, Rubin J, Waldman AT. PMID: 30349849.
      View in: PubMed   Mentions: 1     Fields:    
    56. Altered tryptophan metabolism is associated with pediatric multiple sclerosis risk and course. Ann Clin Transl Neurol. 2018 Oct; 5(10):1211-1221. Nourbakhsh B, Bhargava P, Tremlett H, Hart J, Graves J, Waubant E. PMID: 30349856.
      View in: PubMed   Mentions: 5     Fields:    
    57. Heterogeneity in association of remote herpesvirus infections and pediatric MS. Ann Clin Transl Neurol. 2018 Oct; 5(10):1222-1228. Nourbakhsh B, Rutatangwa A, Waltz M, Rensel M, Moodley M, Graves J, Casper TC, Waldman A, Belman A, Greenberg B, Goyal M, Harris Y, Kahn I, Lotze T, Mar S, Schreiner T, Aaen G, Hart J, Ness J, Rubin J, Tillema JM, Krupp L, Gorman M, Benson L, Rodriguez M, Chitnis T, Rose J, Candee M, Weinstock-Guttman B, Shao X, Barcellos L, James J, Waubant E. PMID: 30349857.
      View in: PubMed   Mentions: 4     Fields:    
    58. Trial of Fingolimod versus Interferon Beta-1a in Pediatric Multiple Sclerosis. N Engl J Med. 2018 09 13; 379(11):1017-1027. Chitnis T, Arnold DL, Banwell B, Brück W, Ghezzi A, Giovannoni G, Greenberg B, Krupp L, Rostásy K, Tardieu M, Waubant E, Wolinsky JS, Bar-Or A, Stites T, Chen Y, Putzki N, Merschhemke M, Gärtner J. PMID: 30207920.
      View in: PubMed   Mentions: 22     Fields:    Translation:HumansPHPublic HealthCTClinical Trials
    59. Editors' Welcome. Mult Scler Relat Disord. 2018 08; 24:A1-A2. Hawkes CH, Giovannoni G, Levy M, Waubant E. PMID: 30190056.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    60. Is cognitive impairment in multiple sclerosis reversible? Mult Scler Relat Disord. 2018 07; 23:A1. Giovannoni G, Hawkes C, Levy M, Waubant E. PMID: 30049507.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    61. Diagnosing and caring for MS in Haiti. Mult Scler Relat Disord. 2018 05; 22:A1-A2. Waubant E, Berkowitz A, Giovannoni G, Hawkes C, Levy M. PMID: 29807822.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    62. Editors' Welcome: Pregnancy and progressive multifocal leukoencephalopathy. Mult Scler Relat Disord. 2018 04; 21:A1-A2. Levy M, Giovannoni G, Hawkes C, Waubant E. PMID: 29724377.
      View in: PubMed   Mentions:    Fields:    Translation:HumansCells
    63. Correction to: Impact of an electronic monitoring device and behavioural feedback on adherence to multiple sclerosis therapies in youth: results of a randomized trial. Qual Life Res. 2018 04; 27(4):1117. Yeh EA, Grover SA, Powell VE, Alper G, Banwell BL, Edwards K, Gorman M, Graves J, Lotze TE, Mah JK, Mednick L, Ness J, Obadia M, Slater R, Waldman A, Waubant E, Schwartz CE. PMID: 29274015.
      View in: PubMed   Mentions:    Fields:    
    64. Early infectious exposures are not associated with increased risk of pediatric-onset multiple sclerosis. Mult Scler Relat Disord. 2018 May; 22:103-107. Suleiman L, Waubant E, Aaen G, Belman A, Benson L, Candee M, Chitnis T, Gorman M, Goyal M, Greenberg B, Harris Y, Hart J, Kahn I, Krupp L, Lotze T, Mar S, Moodley M, Ness J, Nourbakhsh B, Rensel M, Rodriguez M, Rose J, Rubin J, Schreiner T, Tillema JM, Waldman A, Weinstock-Guttman B, Casper TC, Waltz M, Graves JS. PMID: 29653437.
      View in: PubMed   Mentions:    Fields:    Translation:HumansPHPublic Health
    65. Prevalence of salivary human herpesviruses in pediatric multiple sclerosis cases and controls. Mult Scler. 2019 04; 25(5):644-652. Leibovitch EC, Lin CM, Billioux BJ, Graves J, Waubant E, Jacobson S. PMID: 29569515.
      View in: PubMed   Mentions: 1     Fields:    Translation:HumansCells
    66. Multiple sclerosis onset after granulocyte macrophage colony-stimulating factor withdrawal. Mult Scler Relat Disord. 2018 Feb; 20:178-180. Chong J, Cohen M, Waubant E. PMID: 29414294.
      View in: PubMed   Mentions: 1     Fields:    Translation:HumansCTClinical Trials
    67. Editors' Welcome. Mult Scler Relat Disord. 2018 02; 20:A1-A2. Hawkes C, Giovannoni G, Levy M, Waubant E. PMID: 29579630.
      View in: PubMed   Mentions:    Fields:    
    68. Are the high-costs of MS disease-modifying therapies justified? Mult Scler Relat Disord. 2018 02; 20:A3-A5. Giovannoni G, Hawkes C, Levy M, Waubant E. PMID: 29579631.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    69. Gut microbiome and pediatric multiple sclerosis. Mult Scler. 2018 01; 24(1):64-68. Tremlett H, Waubant E. PMID: 29307301.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    70. Editors' Welcome. Mult Scler Relat Disord. 2018 01; 19:A1-A2. Giovannoni G, Hawkes C, Levy M, Lublin F, Waubant E. PMID: 29409600.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    71. The Gut Microbiota and Pediatric Multiple Sclerosis: Recent Findings. Neurotherapeutics. 2018 01; 15(1):102-108. Tremlett H, Waubant E. PMID: 28940049.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    72. Effect of puberty on multiple sclerosis risk and course. Mult Scler. 2018 01; 24(1):32-35. Waubant E. PMID: 29307289.
      View in: PubMed   Mentions: 1     Fields:    Translation:HumansAnimals
    73. Ovarian aging is associated with gray matter volume and disability in women with MS. Neurology. 2018 01 16; 90(3):e254-e260. Graves JS, Henry RG, Cree BAC, Lambert-Messerlian G, Greenblatt RM, Waubant E, Cedars MI, Zhu A, Bacchetti P, Hauser SL, Oksenberg JR. PMID: 29273686.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    74. Diagnosis of multiple sclerosis: 2017 revisions of the McDonald criteria. Lancet Neurol. 2018 02; 17(2):162-173. Thompson AJ, Banwell BL, Barkhof F, Carroll WM, Coetzee T, Comi G, Correale J, Fazekas F, Filippi M, Freedman MS, Fujihara K, Galetta SL, Hartung HP, Kappos L, Lublin FD, Marrie RA, Miller AE, Miller DH, Montalban X, Mowry EM, Sorensen PS, Tintoré M, Traboulsee AL, Trojano M, Uitdehaag BMJ, Vukusic S, Waubant E, Weinshenker BG, Reingold SC, Cohen JA. PMID: 29275977.
      View in: PubMed   Mentions: 315     Fields:    Translation:Humans
    75. Treatment of fatigue with methylphenidate, modafinil and amantadine in multiple sclerosis (TRIUMPHANT-MS): Study design for a pragmatic, randomized, double-blind, crossover clinical trial. Contemp Clin Trials. 2018 01; 64:67-76. Nourbakhsh B, Revirajan N, Waubant E. PMID: 29113955.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    76. Editors' Welcome. Mult Scler Relat Disord. 2017 11; 18:A1-A2. Waubant E, Giovannoni G, Hawkes C, Lublin F. PMID: 29141832.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    77. The multiple sclerosis risk allele within the AHI1 gene is associated with relapses in children and adults. Mult Scler Relat Disord. 2018 Jan; 19:161-165. Graves JS, Barcellos LF, Simpson S, Belman A, Lin R, Taylor BV, Ponsonby AL, Dwyer T, Krupp L, Waubant E, van der Mei IAF. PMID: 29409597.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    78. Contribution of dietary intake to relapse rate in early paediatric multiple sclerosis. J Neurol Neurosurg Psychiatry. 2018 01; 89(1):28-33. Azary S, Schreiner T, Graves J, Waldman A, Belman A, Guttman BW, Aaen G, Tillema JM, Mar S, Hart J, Ness J, Harris Y, Krupp L, Gorman M, Benson L, Rodriguez M, Chitnis T, Rose J, Barcellos LF, Lotze T, Carmichael SL, Roalstad S, Casper CT, Waubant E. PMID: 28993476.
      View in: PubMed   Mentions: 7     Fields:    Translation:HumansAnimals
    79. Genetic risk factors for pediatric-onset multiple sclerosis. Mult Scler. 2018 12; 24(14):1825-1834. Gianfrancesco MA, Stridh P, Shao X, Rhead B, Graves JS, Chitnis T, Waldman A, Lotze T, Schreiner T, Belman A, Greenberg B, Weinstock-Guttman B, Aaen G, Tillema JM, Hart J, Caillier S, Ness J, Harris Y, Rubin J, Candee M, Krupp L, Gorman M, Benson L, Rodriguez M, Mar S, Kahn I, Rose J, Roalstad S, Casper TC, Shen L, Quach H, Quach D, Hillert J, Hedstrom A, Olsson T, Kockum I, Alfredsson L, Schaefer C, Barcellos LF, Waubant E. PMID: 28980494.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    80. Editors' Welcome. Mult Scler Relat Disord. 2017 10; 17:A1-A2. Lublin F, Giovannoni G, Hawkes C, Waubant E. PMID: 29055486.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    81. Performance of 2010 McDonald criteria and 2016 MAGNIMS guidelines in the diagnosis of primary progressive multiple sclerosis. J Neurol Neurosurg Psychiatry. 2018 05; 89(5):550-552. Gajofatto A, Nourbakhsh B, Benedetti MD, Waubant E. PMID: 28939685.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    82. Examining the contributions of environmental quality to pediatric multiple sclerosis. Mult Scler Relat Disord. 2017 Nov; 18:164-169. Lavery AM, Waldman AT, Charles Casper T, Roalstad S, Candee M, Rose J, Belman A, Weinstock-Guttman B, Aaen G, Tillema JM, Rodriguez M, Ness J, Harris Y, Graves J, Krupp L, Benson L, Gorman M, Moodley M, Rensel M, Goyal M, Mar S, Chitnis T, Schreiner T, Lotze T, Greenberg B, Kahn I, Rubin J, Waubant E. PMID: 29141802.
      View in: PubMed   Mentions: 1     Fields:    Translation:HumansPHPublic Health
    83. Editors' Welcome. Mult Scler Relat Disord. 2017 08; 16:A1-A2. Hawkes C, Giovannoni G, Lublin F, Waubant E. PMID: 28755685.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    84. Genetic variation in the gene LRP2 increases relapse risk in multiple sclerosis. J Neurol Neurosurg Psychiatry. 2017 10; 88(10):864-868. Zhou Y, Graves JS, Simpson S, Charlesworth JC, Mei IV, Waubant E, Barcellos LF, Belman A, Krupp L, Lucas R, Ponsonby AL, Taylor BV. PMID: 28739605.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    85. Psychiatric disorders in children with demyelinating diseases of the central nervous system. Mult Scler. 2018 08; 24(9):1243-1250. Pakpoor J, Goldacre R, Schmierer K, Giovannoni G, Waubant E, Goldacre MJ. PMID: 28675955.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    86. The 'Field Hypothesis': rebound activity after stopping disease-modifying therapies. Mult Scler Relat Disord. 2017 07; 15:A1-A2. Giovannoni G, Hawkes C, Waubant E, Lublin F. PMID: 28641776.
      View in: PubMed   Mentions:    Fields:    Translation:HumansAnimals
    87. Dietary factors and pediatric multiple sclerosis: A case-control study. Mult Scler. 2018 07; 24(8):1067-1076. Pakpoor J, Seminatore B, Graves JS, Schreiner T, Waldman AT, Lotze TE, Belman A, Greenberg BM, Weinstock-Guttman B, Aaen G, Tillema JM, McDonald JC, Hart J, Ness JM, Harris Y, Rubin J, Candee M, Krupp L, Gorman M, Benson L, Rodriguez M, Chitnis T, Mar S, Kahn I, Rose J, Carmichael SL, Roalstad S, Waltz M, Casper TC, Waubant E. PMID: 28608728.
      View in: PubMed   Mentions: 5     Fields:    Translation:Humans
    88. Clinical Reasoning: A 16-year-old girl with subacute weakness and sensory loss. Neurology. 2017 06 06; 88(23):e225-e229. Quintanilla-Bordás C, Nourbakhsh B, Strober J, Raffel C, Waubant E. PMID: 28583938.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    89. Editors' welcome. Mult Scler Relat Disord. 2017 05; 14:A1-A2. Waubant E, Giovannoni G, Hawkes C, Lublin F. PMID: 28619438.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    90. Impact of an electronic monitoring device and behavioral feedback on adherence to multiple sclerosis therapies in youth: results of a randomized trial. Qual Life Res. 2017 09; 26(9):2333-2349. Yeh EA, Grover SA, Powell VE, Alper G, Banwell BL, Edwards K, Gorman M, Graves J, Lotze TE, Mah JK, Mednick L, Ness J, Obadia M, Slater R, Waldman A, Waubant E, Schwartz CE. PMID: 28393317.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    91. Maternal and Perinatal Exposures Are Associated With Risk for Pediatric-Onset Multiple Sclerosis. Pediatrics. 2017 Apr; 139(4). Graves JS, Chitnis T, Weinstock-Guttman B, Rubin J, Zelikovitch AS, Nourbakhsh B, Simmons T, Waltz M, Casper TC, Waubant E. PMID: 28562303.
      View in: PubMed   Mentions: 4     Fields:    Translation:HumansPHPublic Health
    92. Editors' Welcome. Mult Scler Relat Disord. 2017 04; 13:A1. Lublin F, Giovannoni G, Hawkes C, Waubant E. PMID: 28427712.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    93. Evidence for a causal relationship between low vitamin D, high BMI, and pediatric-onset MS. Neurology. 2017 Apr 25; 88(17):1623-1629. Gianfrancesco MA, Stridh P, Rhead B, Shao X, Xu E, Graves JS, Chitnis T, Waldman A, Lotze T, Schreiner T, Belman A, Greenberg B, Weinstock-Guttman B, Aaen G, Tillema JM, Hart J, Caillier S, Ness J, Harris Y, Rubin J, Candee M, Krupp L, Gorman M, Benson L, Rodriguez M, Mar S, Kahn I, Rose J, Roalstad S, Casper TC, Shen L, Quach H, Quach D, Hillert J, Bäärnhielm M, Hedstrom A, Olsson T, Kockum I, Alfredsson L, Metayer C, Schaefer C, Barcellos LF, Waubant E. PMID: 28356466.
      View in: PubMed   Mentions: 23     Fields:    Translation:Humans
    94. The gut microbiome in human neurological disease: A review. Ann Neurol. 2017 Mar; 81(3):369-382. Tremlett H, Bauer KC, Appel-Cresswell S, Finlay BB, Waubant E. PMID: 28220542.
      View in: PubMed   Mentions: 77     Fields:    Translation:HumansAnimals
    95. Editors' Welcome. Mult Scler Relat Disord. 2017 02; 12:A1-A2. Hawkes C, Giovannoni G, Lublin F, Waubant E. PMID: 28283115.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    96. The multiple sclerosis microbiome? Ann Transl Med. 2017 Feb; 5(3):53. Tremlett H, Waubant E. PMID: 28251132.
      View in: PubMed   Mentions:
    97. Risk factors for non-adherence to disease-modifying therapy in pediatric multiple sclerosis. Mult Scler. 2018 02; 24(2):175-185. Schwartz CE, Grover SA, Powell VE, Noguera A, Mah JK, Mar S, Mednick L, Banwell BL, Alper G, Rensel M, Gorman M, Waldman A, Schreiner T, Waubant E, Yeh EA. PMID: 28273780.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    98. Serum neurofilament is associated with progression of brain atrophy and disability in early MS. Neurology. 2017 Feb 28; 88(9):826-831. Kuhle J, Nourbakhsh B, Grant D, Morant S, Barro C, Yaldizli Ö, Pelletier D, Giovannoni G, Waubant E, Gnanapavan S. PMID: 28148632.
      View in: PubMed   Mentions: 29     Fields:    Translation:Humans
    99. Editors' Welcome. Mult Scler Relat Disord. 2017 Jan; 11:A1-A2. Giovannoni G, Hawkes C, Lublin F, Waubant E. PMID: 28104262.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    100. Distinct effects of obesity and puberty on risk and age at onset of pediatric MS. Ann Clin Transl Neurol. 2016 12; 3(12):897-907. Chitnis T, Graves J, Weinstock-Guttman B, Belman A, Olsen C, Misra M, Aaen G, Benson L, Candee M, Gorman M, Greenberg B, Krupp L, Lotze T, Mar S, Ness J, Rose J, Rubin J, Schreiner T, Tillema J, Waldman A, Rodriguez M, Casper C, Waubant E. PMID: 28097202.
      View in: PubMed   Mentions: 13     Fields:    
    101. Rebound Syndrome in Multiple Sclerosis After Fingolimod Cessation-Reply. JAMA Neurol. 2016 11 01; 73(11):1376. Hatcher SE, Waubant E, Graves JS. PMID: 27669526.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    102. Editors' Welcome. Mult Scler Relat Disord. 2016 Nov; 10:A1. Hawkes C, Lublin F, Giovannoni G, Waubant E. PMID: 27919509.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    103. Associations between the gut microbiota and host immune markers in pediatric multiple sclerosis and controls. BMC Neurol. 2016 Sep 21; 16(1):182. Tremlett H, Fadrosh DW, Faruqi AA, Hart J, Roalstad S, Graves J, Spencer CM, Lynch SV, Zamvil SS, Waubant E. PMID: 27652609.
      View in: PubMed   Mentions: 23     Fields:    
    104. International Pediatric MS Study Group Global Members Symposium report. Neurology. 2016 Aug 30; 87(9 Suppl 2):S110-6. Wassmer E, Chitnis T, Pohl D, Amato MP, Banwell B, Ghezzi A, Hintzen RQ, Krupp LB, Makhani N, Rostásy K, Tardieu M, Tenembaum S, Waldman A, Waubant E, Kornberg AJ. PMID: 27572855.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    105. Environmental and genetic factors in pediatric inflammatory demyelinating diseases. Neurology. 2016 Aug 30; 87(9 Suppl 2):S20-7. Waubant E, Ponsonby AL, Pugliatti M, Hanwell H, Mowry EM, Hintzen RQ. PMID: 27572857.
      View in: PubMed   Mentions: 6     Fields:    Translation:Humans
    106. Biopsy-Supported Tumefactive Demyelination of the Central Nervous System in Children. J Child Neurol. 2016 12; 31(14):1528-1533. Hanumanthe SB, Francisco C, Hart J, Graves J, Waubant E. PMID: 27572815.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    107. Clinical trials for pediatric MS should be prioritized to test only one or two of the most promising agents - NO. Mult Scler. 2016 11; 22(13):1651-1653. Francisco C, Graves J, Waubant E. PMID: 27473402.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    108. Fatigue and depression predict quality of life in patients with early multiple sclerosis: a longitudinal study. Eur J Neurol. 2016 09; 23(9):1482-6. Nourbakhsh B, Julian L, Waubant E. PMID: 27416110.
      View in: PubMed   Mentions: 10     Fields:    Translation:Humans
    109. Sex differences and subclinical retinal injury in pediatric-onset MS. Mult Scler. 2017 Mar; 23(3):447-455. Graves JS, Chohan H, Cedars B, Arnow S, Yiu H, Waubant E, Green A. PMID: 27306618.
      View in: PubMed   Mentions: 5     Fields:    Translation:HumansCells
    110. Characteristics of Children and Adolescents With Multiple Sclerosis. Pediatrics. 2016 07; 138(1). Belman AL, Krupp LB, Olsen CS, Rose JW, Aaen G, Benson L, Chitnis T, Gorman M, Graves J, Harris Y, Lotze T, Ness J, Rodriguez M, Tillema JM, Waubant E, Weinstock-Guttman B, Casper TC. PMID: 27358474.
      View in: PubMed   Mentions: 16     Fields:    Translation:Humans
    111. Rebound Syndrome in Patients With Multiple Sclerosis After Cessation of Fingolimod Treatment. JAMA Neurol. 2016 07 01; 73(7):790-4. Hatcher SE, Waubant E, Nourbakhsh B, Crabtree-Hartman E, Graves JS. PMID: 27135594.
      View in: PubMed   Mentions: 32     Fields:    Translation:Humans
    112. Dietary salt intake and time to relapse in paediatric multiple sclerosis. J Neurol Neurosurg Psychiatry. 2016 12; 87(12):1350-1353. Nourbakhsh B, Graves J, Casper TC, Lulu S, Waldman A, Belman A, Greenberg B, Weinstock-Guttman B, Aaen G, Tillema JM, Hart J, Ness J, Rubin J, Krupp L, Gorman M, Benson L, Rodriguez M, Chitnis T, Rose J, Barcellos L, Waubant E. PMID: 27343226.
      View in: PubMed   Mentions: 16     Fields:    Translation:Humans
    113. Gut microbiota in early pediatric multiple sclerosis: a case-control study. Eur J Neurol. 2016 Aug; 23(8):1308-1321. Tremlett H, Fadrosh DW, Faruqi AA, Zhu F, Hart J, Roalstad S, Graves J, Lynch S, Waubant E. PMID: 27176462.
      View in: PubMed   Mentions: 48     Fields:    Translation:Humans
    114. Subcortical grey matter volumes predict subsequent walking function in early multiple sclerosis. J Neurol Sci. 2016 Jul 15; 366:229-233. Nourbakhsh B, Azevedo C, Maghzi AH, Spain R, Pelletier D, Waubant E. PMID: 27288812.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    115. Clinical Reasoning: Left hemiparesis, ataxia, and optic neuritis in a child previously treated for pineoblastoma. Neurology. 2016 04 12; 86(15):e161-e165. Vila-Bedmar S, Nourbakhsh B, Anzalone S, Waubant E. PMID: 27163667.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    116. Gut microbiota composition and relapse risk in pediatric MS: A pilot study. J Neurol Sci. 2016 Apr 15; 363:153-7. Tremlett H, Fadrosh DW, Faruqi AA, Hart J, Roalstad S, Graves J, Lynch S, Waubant E. PMID: 27000242.
      View in: PubMed   Mentions: 38     Fields:    Translation:Humans
    117. The challenge of comorbidity in clinical trials for multiple sclerosis. Neurology. 2016 Apr 12; 86(15):1437-1445. Marrie RA, Miller A, Sormani MP, Thompson A, Waubant E, Trojano M, O'Connor P, Reingold S, Cohen JA. PMID: 26888986.
      View in: PubMed   Mentions: 8     Fields:    Translation:Humans
    118. A case-control study of dietary salt intake in pediatric-onset multiple sclerosis. Mult Scler Relat Disord. 2016 Mar; 6:87-92. McDonald J, Graves J, Waldman A, Lotze T, Schreiner T, Belman A, Greenberg B, Weinstock-Guttman B, Aaen G, Tillema JM, Hart J, Lulu S, Ness J, Harris Y, Rubin J, Candee M, Krupp LB, Gorman M, Benson L, Rodriguez M, Chitnis T, Mar S, Barcellos LF, Laraia B, Rose J, Roalstad S, Simmons T, Casper TC, Waubant E. PMID: 27063630.
      View in: PubMed   Mentions: 15     Fields:    Translation:Humans
    119. Recommendations for observational studies of comorbidity in multiple sclerosis. Neurology. 2016 Apr 12; 86(15):1446-1453. Marrie RA, Miller A, Sormani MP, Thompson A, Waubant E, Trojano M, O'Connor P, Fiest K, Reider N, Reingold S, Cohen JA. PMID: 26865523.
      View in: PubMed   Mentions: 11     Fields:    Translation:Humans
    120. Genetic predictors of relapse rate in pediatric MS. Mult Scler. 2016 10; 22(12):1528-1535. Graves JS, Barcellos LF, Shao X, Noble J, Mowry EM, Quach H, Belman A, Casper TC, Krupp LB, Waubant E. PMID: 26769066.
      View in: PubMed   Mentions: 7     Fields:    Translation:Humans
    121. Clinical features of neuromyelitis optica in children: US Network of Pediatric MS Centers report. Neurology. 2016 Jan 19; 86(3):245-52. Chitnis T, Ness J, Krupp L, Waubant E, Hunt T, Olsen CS, Rodriguez M, Lotze T, Gorman M, Benson L, Belman A, Weinstock-Guttman B, Aaen G, Graves J, Patterson M, Rose JW, Casper TC. PMID: 26683648.
      View in: PubMed   Mentions: 16     Fields:    Translation:Humans
    122. Acute Flaccid Myelitis of Unknown Etiology in California, 2012-2015. JAMA. 2015 Dec 22-29; 314(24):2663-71. Van Haren K, Ayscue P, Waubant E, Clayton A, Sheriff H, Yagi S, Glenn-Finer R, Padilla T, Strober JB, Aldrovandi G, Wadford DA, Chiu CY, Xia D, Harriman K, Watt JP, Glaser CA. PMID: 26720027.
      View in: PubMed   Mentions: 24     Fields:    Translation:HumansCells
    123. Association Between Glutamate Blockade and Fatigue in Patients With Multiple Sclerosis. JAMA Neurol. 2015 Nov; 72(11):1374-5. Nourbakhsh B, Revirajan N, Waubant E. PMID: 26551959.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    124. Longitudinal associations between MRI and cognitive changes in very early MS. Mult Scler Relat Disord. 2016 Jan; 5:47-52. Nourbakhsh B, Nunan-Saah J, Maghzi AH, Julian LJ, Spain R, Jin C, Lazar A, Pelletier D, Waubant E. PMID: 26856943.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    125. Longitudinal associations between brain structural changes and fatigue in early MS. Mult Scler Relat Disord. 2016 Jan; 5:29-33. Nourbakhsh B, Azevedo C, Nunan-Saah J, Maghzi AH, Spain R, Pelletier D, Waubant E. PMID: 26856940.
      View in: PubMed   Mentions: 13     Fields:    Translation:Humans
    126. Relapses in multiple sclerosis: Relationship to disability. Mult Scler Relat Disord. 2016 Mar; 6:10-20. Goodin DS, Reder AT, Bermel RA, Cutter GR, Fox RJ, John GR, Lublin FD, Lucchinetti CF, Miller AE, Pelletier D, Racke MK, Trapp BD, Vartanian T, Waubant E. PMID: 27063617.
      View in: PubMed   Mentions: 6     Fields:    Translation:Humans
    127. Multiple sclerosis patients have a diminished serologic response to vitamin D supplementation compared to healthy controls. Mult Scler. 2016 05; 22(6):753-60. Bhargava P, Steele SU, Waubant E, Revirajan NR, Marcus J, Dembele M, Cassard SD, Hollis BW, Crainiceanu C, Mowry EM. PMID: 26286698.
      View in: PubMed   Mentions: 8     Fields:    Translation:Humans
    128. Association Between Thoracic Spinal Cord Gray Matter Atrophy and Disability in Multiple Sclerosis. JAMA Neurol. 2015 Aug; 72(8):897-904. Schlaeger R, Papinutto N, Zhu AH, Lobach IV, Bevan CJ, Bucci M, Castellano A, Gelfand JM, Graves JS, Green AJ, Jordan KM, Keshavan A, Panara V, Stern WA, von Büdingen HC, Waubant E, Goodin DS, Cree BA, Hauser SL, Henry RG. PMID: 26053119.
      View in: PubMed   Mentions: 19     Fields:    Translation:Humans
    129. Update on biomarkers in neuromyelitis optica. Neurol Neuroimmunol Neuroinflamm. 2015 Aug; 2(4):e134. Melamed E, Levy M, Waters PJ, Sato DK, Bennett JL, John GR, Hooper DC, Saiz A, Bar-Or A, Kim HJ, Pandit L, Leite MI, Asgari N, Kissani N, Hintzen R, Marignier R, Jarius S, Marcelletti J, Smith TJ, Yeaman MR, Han MH, Aktas O, Apiwattanakul M, Banwell B, Bichuetti D, Broadley S, Cabre P, Chitnis T, De Seze J, Fujihara K, Greenberg B, Hellwig K, Iorio R, Jarius S, Klawiter E, Kleiter I, Lana-Peixoto M, O'Connor K, Palace J, Paul F, Prayoonwiwat N, Ruprecht K, Stuve O, Tedder T, Tenembaum S, Garrahan JP, Aires B, van Herle K, van Pelt D, Villoslada P, Waubant E, Weinshenker B, Wingerchuk D, Würfel J, Zamvil S. PMID: 26236760.
      View in: PubMed   Mentions: 23     Fields:    
    130. Neuropsychological correlates of multiple sclerosis across the lifespan. Mult Scler. 2015 Oct; 21(11):1355-64. Nunan-Saah J, Paulraj SR, Waubant E, Krupp LB, Gomez RG. PMID: 26163074.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    131. Use of Advanced Magnetic Resonance Imaging Techniques in Neuromyelitis Optica Spectrum Disorder. JAMA Neurol. 2015 Jul; 72(7):815-22. Kremer S, Renard F, Achard S, Lana-Peixoto MA, Palace J, Asgari N, Klawiter EC, Tenembaum SN, Banwell B, Greenberg BM, Bennett JL, Levy M, Villoslada P, Saiz A, Fujihara K, Chan KH, Schippling S, Paul F, Kim HJ, de Seze J, Wuerfel JT, Cabre P, Marignier R, Tedder T, van Pelt D, Broadley S, Chitnis T, Wingerchuk D, Pandit L, Leite MI, Apiwattanakul M, Kleiter I, Prayoonwiwat N, Han M, Hellwig K, van Herle K, John G, Hooper DC, Nakashima I, Sato D, Yeaman MR, Waubant E, Zamvil S, Stüve O, Aktas O, Smith TJ, Jacob A, O'Connor K. PMID: 26010909.
      View in: PubMed   Mentions: 19     Fields:    Translation:Humans
    132. Gut microbiota in multiple sclerosis: possible influence of immunomodulators. J Investig Med. 2015 Jun; 63(5):729-34. Cantarel BL, Waubant E, Chehoud C, Kuczynski J, DeSantis TZ, Warrington J, Venkatesan A, Fraser CM, Mowry EM. PMID: 25775034.
      View in: PubMed   Mentions: 69     Fields:    Translation:Humans
    133. Menarche increases relapse risk in pediatric multiple sclerosis. Mult Scler. 2016 Feb; 22(2):193-200. Lulu S, Graves J, Waubant E. PMID: 25948626.
      View in: PubMed   Mentions: 11     Fields:    Translation:Humans
    134. Retinal axonal loss in very early stages of multiple sclerosis. Eur J Neurol. 2015 Jul; 22(7):1138-41. Maghzi AH, Graves J, Revirajan N, Spain R, Liu S, McCulloch CE, Pelletier D, Green AJ, Waubant E. PMID: 25929276.
      View in: PubMed   Mentions: 1     Fields:    Translation:HumansCells
    135. Patient preferences for attributes of multiple sclerosis disease-modifying therapies: development and results of a ratings-based conjoint analysis. Int J MS Care. 2015 Mar-Apr; 17(2):74-82. Wilson LS, Loucks A, Gipson G, Zhong L, Bui C, Miller E, Owen M, Pelletier D, Goodin D, Waubant E, McCulloch CE. PMID: 25892977.
      View in: PubMed   Mentions:
    136. Prolonged Remission in Neuromyelitis Optica Following Cessation of Rituximab Treatment. J Child Neurol. 2015 Sep; 30(10):1366-70. Weinfurtner K, Graves J, Ness J, Krupp L, Milazzo M, Waubant E. PMID: 25387545.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    137. Treatment adherence and transitioning youth in pediatric multiple sclerosis. Mult Scler Relat Disord. 2014 Nov; 3(6):689-95. Lulu S, Julian L, Shapiro E, Hudson K, Waubant E. PMID: 25798373.
      View in: PubMed   Mentions: 7     Fields:    Translation:Humans
    138. Protective environmental factors for neuromyelitis optica. Neurology. 2014 Nov 18; 83(21):1923-9. Graves J, Grandhe S, Weinfurtner K, Krupp L, Belman A, Chitnis T, Ness J, Weinstock-Guttman B, Gorman M, Patterson M, Rodriguez M, Lotze T, Aaen G, Mowry EM, Rose JW, Simmons T, Casper TC, James J, Waubant E. PMID: 25339213.
      View in: PubMed   Mentions: 1     Fields:    Translation:HumansCells
    139. Precision medicine in chronic disease management: The multiple sclerosis BioScreen. Ann Neurol. 2014 Nov; 76(5):633-42. Gourraud PA, Henry RG, Cree BA, Crane JC, Lizee A, Olson MP, Santaniello AV, Datta E, Zhu AH, Bevan CJ, Gelfand JM, Graves JS, Goodin DS, Green AJ, von Büdingen HC, Waubant E, Zamvil SS, Crabtree-Hartman E, Nelson S, Baranzini SE, Hauser SL. PMID: 25263997.
      View in: PubMed   Mentions: 16     Fields:    Translation:Humans
    140. The vitamin D to ameliorate multiple sclerosis (VIDAMS) trial: study design for a multicenter, randomized, double-blind controlled trial of vitamin D in multiple sclerosis. Contemp Clin Trials. 2014 Nov; 39(2):288-93. Bhargava P, Cassard S, Steele SU, Azevedo C, Pelletier D, Sugar EA, Waubant E, Mowry EM. PMID: 25311447.
      View in: PubMed   Mentions: 27     Fields:    Translation:Humans
    141. Acute flaccid paralysis with anterior myelitis - California, June 2012-June 2014. MMWR Morb Mortal Wkly Rep. 2014 Oct 10; 63(40):903-6. Ayscue P, Van Haren K, Sheriff H, Waubant E, Waldron P, Yagi S, Yen C, Clayton A, Padilla T, Pan C, Reichel J, Harriman K, Watt J, Sejvar J, Nix WA, Feikin D, Glaser C. PMID: 25299608.
      View in: PubMed   Mentions: 27     Fields:    Translation:HumansCells
    142. The US Network of Pediatric Multiple Sclerosis Centers: Development, Progress, and Next Steps. J Child Neurol. 2015 Sep; 30(10):1381-7. Casper TC, Rose JW, Roalstad S, Waubant E, Aaen G, Belman A, Chitnis T, Gorman M, Krupp L, Lotze TE, Ness J, Patterson M, Rodriguez M, Weinstock-Guttman B, Browning B, Graves J, Tillema JM, Benson L, Harris Y. PMID: 25270659.
      View in: PubMed   Mentions: 8     Fields:    Translation:Humans
    143. Spinal cord gray matter atrophy correlates with multiple sclerosis disability. Ann Neurol. 2014 Oct; 76(4):568-80. Schlaeger R, Papinutto N, Panara V, Bevan C, Lobach IV, Bucci M, Caverzasi E, Gelfand JM, Green AJ, Jordan KM, Stern WA, von Büdingen HC, Waubant E, Zhu AH, Goodin DS, Cree BA, Hauser SL, Henry RG. PMID: 25087920.
      View in: PubMed   Mentions: 47     Fields:    Translation:Humans
    144. Magnetic resonance imaging correlates of clinical outcomes in early multiple sclerosis. Mult Scler Relat Disord. 2014 Nov; 3(6):720-7. Maghzi AH, Revirajan N, Julian LJ, Spain R, Mowry EM, Liu S, Jin C, Green AJ, McCulloch CE, Pelletier D, Waubant E. PMID: 25891551.
      View in: PubMed   Mentions: 9     Fields:    Translation:Humans
    145. Patient centered decision making: use of conjoint analysis to determine risk-benefit trade-offs for preference sensitive treatment choices. J Neurol Sci. 2014 Sep 15; 344(1-2):80-7. Wilson L, Loucks A, Bui C, Gipson G, Zhong L, Schwartzburg A, Crabtree E, Goodin D, Waubant E, McCulloch C. PMID: 25037284.
      View in: PubMed   Mentions: 21     Fields:    Translation:Humans
    146. B-cell depletion in children with neuroimmunologic conditions: the learning curve. Neurology. 2014 Jul 08; 83(2):111-2. Chitnis T, Waubant E. PMID: 24920852.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    147. Defining the clinical course of multiple sclerosis: the 2013 revisions. Neurology. 2014 Jul 15; 83(3):278-86. Lublin FD, Reingold SC, Cohen JA, Cutter GR, Sørensen PS, Thompson AJ, Wolinsky JS, Balcer LJ, Banwell B, Barkhof F, Bebo B, Calabresi PA, Clanet M, Comi G, Fox RJ, Freedman MS, Goodman AD, Inglese M, Kappos L, Kieseier BC, Lincoln JA, Lubetzki C, Miller AE, Montalban X, O'Connor PW, Petkau J, Pozzilli C, Rudick RA, Sormani MP, Stüve O, Waubant E, Polman CH. PMID: 24871874.
      View in: PubMed   Mentions: 350     Fields:    Translation:Humans
    148. A randomized controlled phase II trial of riluzole in early multiple sclerosis. Ann Clin Transl Neurol. 2014 May; 1(5):340-7. Waubant E, Maghzi AH, Revirajan N, Spain R, Julian L, Mowry EM, Marcus J, Liu S, Jin C, Green A, McCulloch CE, Pelletier D. PMID: 25356404.
      View in: PubMed   Mentions: 7     Fields:    
    149. Atypical cases of scleroderma en coup de sabre. J Child Neurol. 2014 May; 29(5):698-703. Kraus V, Lawson EF, von Scheven E, Tihan T, Garza J, Nathan RG, Cordoro KM, Waubant E. PMID: 24667737.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    150. Longitudinally extensive optic neuritis in pediatric patients. J Child Neurol. 2015 Jan; 30(1):120-3. Graves J, Kraus V, Soares BP, Hess CP, Waubant E. PMID: 24563470.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    151. Rituximab use in pediatric central demyelinating disease. Pediatr Neurol. 2014 Jul; 51(1):114-8. Beres SJ, Graves J, Waubant E. PMID: 24768216.
      View in: PubMed   Mentions: 17     Fields:    Translation:Humans
    152. MS and related disorders: groundbreaking news. Lancet Neurol. 2014 Jan; 13(1):11-3. Waubant E, Cross A. PMID: 24331785.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    153. Quantitative MRI analysis in children with multiple sclerosis: a multicenter feasibility pilot study. BMC Neurol. 2013 Nov 13; 13:173. Chitnis T, Guttmann CR, Zaitsev A, Musallam A, Weinstock-Guttman B, Yeh A, Rodriguez M, Ness J, Gorman MP, Healy BC, Kuntz N, Chabas D, Strober JB, Waubant E, Krupp L, Pelletier D, Erickson B, Bergsland N, Zivadinov R. PMID: 24225378.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    154. Effects of rituximab on lymphocytes in multiple sclerosis and neuromyelitis optica. Mult Scler Relat Disord. 2014 Mar; 3(2):244-52. Graves J, Vinayagasundaram U, Mowry EM, Matthews IR, Marino JA, Cheng J, Waubant E. PMID: 25878012.
      View in: PubMed   Mentions: 9     Fields:    
    155. Association of multiple sclerosis susceptibility variants and early attack location in the CNS. PLoS One. 2013; 8(10):e75565. Mowry EM, Carey RF, Blasco MR, Pelletier J, Duquette P, Villoslada P, Malikova I, Roger E, Kinkel RP, McDonald J, Bacchetti P, Waubant E. PMID: 24130718.
      View in: PubMed   Mentions: 5     Fields:    Translation:Humans
    156. Multiple sclerosis susceptibility genes: associations with relapse severity and recovery. PLoS One. 2013; 8(10):e75416. Mowry EM, Carey RF, Blasco MR, Pelletier J, Duquette P, Villoslada P, Malikova I, Roger E, Kinkel RP, McDonald J, Bacchetti P, Waubant E. PMID: 24130709.
      View in: PubMed   Mentions: 8     Fields:    Translation:Humans
    157. Neuroprotection in multiple sclerosis: a therapeutic approach. CNS Drugs. 2013 Oct; 27(10):799-815. Maghzi AH, Minagar A, Waubant E. PMID: 23955320.
      View in: PubMed   Mentions: 4     Fields:    Translation:HumansCells
    158. Rituximab in relapsing and progressive forms of multiple sclerosis: a systematic review. PLoS One. 2013; 8(7):e66308. Castillo-Trivino T, Braithwaite D, Bacchetti P, Waubant E. PMID: 23843952.
      View in: PubMed   Mentions: 29     Fields:    Translation:Humans
    159. Therapeutic advances in pediatric multiple sclerosis. J Pediatr. 2013 Sep; 163(3):631-7. Van Haren K, Waubant E. PMID: 23726542.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    160. Updates on clinically isolated syndrome and diagnostic criteria for multiple sclerosis. Neurohospitalist. 2013 Apr; 3(2):65-80. Marcus JF, Waubant EL. PMID: 23983889.
      View in: PubMed   Mentions:
    161. International Pediatric MS Study Group Clinical Trials Summit: meeting report. Neurology. 2013 Mar 19; 80(12):1161-8. Chitnis T, Tardieu M, Amato MP, Banwell B, Bar-Or A, Ghezzi A, Kornberg A, Krupp LB, Pohl D, Rostasy K, Tenembaum S, Waubant E, Wassmer E. PMID: 23509048.
      View in: PubMed   Mentions: 15     Fields:    Translation:Humans
    162. Humoral-targeted immunotherapies in multiple sclerosis. Neurotherapeutics. 2013 Jan; 10(1):34-43. Lulu S, Waubant E. PMID: 23208729.
      View in: PubMed   Mentions: 5     Fields:    Translation:HumansAnimalsCells
    163. Copy number variation in pediatric multiple sclerosis. Mult Scler. 2013 Jul; 19(8):1014-21. McElroy JP, Krupp LB, Johnson BA, McCauley JL, Qi Z, Caillier SJ, Gourraud PA, Yu J, Nathanson L, Belman AL, Hauser SL, Waubant E, Hedges DJ, Oksenberg JR. PMID: 23239789.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    164. Antibody response to common viruses and human leukocyte antigen-DRB1 in pediatric multiple sclerosis. Mult Scler. 2013 Jun; 19(7):891-5. Waubant E, Mowry EM, Krupp L, Chitnis T, Yeh EA, Kuntz N, Ness J, Belman A, Milazzo M, Gorman M, Weinstock-Guttman B, Rodriguez M, James JA. PMID: 23232601.
      View in: PubMed   Mentions: 6     Fields:    Translation:Humans
    165. Cognitive impairment occurs in children and adolescents with multiple sclerosis: results from a United States network. J Child Neurol. 2013 Jan; 28(1):102-7. Julian L, Serafin D, Charvet L, Ackerson J, Benedict R, Braaten E, Brown T, O'Donnell E, Parrish J, Preston T, Zaccariello M, Belman A, Chitnis T, Gorman M, Ness J, Patterson M, Rodriguez M, Waubant E, Weinstock-Guttman B, Yeh A, Krupp LB. PMID: 23155206.
      View in: PubMed   Mentions: 24     Fields:    Translation:Humans
    166. EDSS variability before randomization may limit treatment discovery in primary progressive MS. Mult Scler. 2013 May; 19(6):775-81. Zhang J, Waubant E, Cutter G, Wolinsky JS, Glanzman R. PMID: 23027880.
      View in: PubMed   Mentions: 6     Fields:    Translation:HumansCTClinical Trials
    167. Treatment of Neuromyelitis Optica: Review and Recommendations. Mult Scler Relat Disord. 2012 Oct; 1(4):180-187. Kimbrough DJ, Fujihara K, Jacob A, Lana-Peixoto MA, Leite MI, Levy M, Marignier R, Nakashima I, Palace J, de Seze J, Stuve O, Tenembaum SN, Traboulsee A, Waubant E, Weinshenker BG, Wingerchuk DM. PMID: 24555176.
      View in: PubMed   Mentions: 50     Fields:    
    168. Vitamin D status predicts new brain magnetic resonance imaging activity in multiple sclerosis. Ann Neurol. 2012 Aug; 72(2):234-40. Mowry EM, Waubant E, McCulloch CE, Okuda DT, Evangelista AA, Lincoln RR, Gourraud PA, Brenneman D, Owen MC, Qualley P, Bucci M, Hauser SL, Pelletier D. PMID: 22926855.
      View in: PubMed   Mentions: 60     Fields:    Translation:Humans
    169. Antibodies to potassium channels in multiple sclerosis. N Engl J Med. 2012 Jul 12; 367(2):172-4. Cross AH, Waubant E. PMID: 22784120.
      View in: PubMed   Mentions: 2     Fields:    Translation:HumansAnimals
    170. Overview of treatment options in multiple sclerosis. J Clin Psychiatry. 2012 Jun; 73(6):e22. Waubant E. PMID: 22795209.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    171. Early recognition and diagnosis of multiple sclerosis. J Clin Psychiatry. 2012 Apr; 73(4):e14. Waubant E. PMID: 22579157.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    172. Randomized controlled trial of atorvastatin in clinically isolated syndrome: the STAyCIS study. Neurology. 2012 Apr 10; 78(15):1171-8. Waubant E, Pelletier D, Mass M, Cohen JA, Kita M, Cross A, Bar-Or A, Vollmer T, Racke M, Stüve O, Schwid S, Goodman A, Kachuck N, Preiningerova J, Weinstock-Guttman B, Calabresi PA, Miller A, Mokhtarani M, Iklé D, Murphy S, Kopetskie H, Ding L, Rosenberg E, Spencer C, Zamvil SS. PMID: 22459680.
      View in: PubMed   Mentions: 16     Fields:    Translation:HumansCTClinical Trials
    173. Unilateral thalamic deep brain stimulation for disabling kinetic tremor in multiple sclerosis. Neurosurgery. 2012 Jan; 70(1):66-9. Hosseini H, Mandat T, Waubant E, Agid Y, Lubetzki C, Lyon-Caen O, Stankoff B, Jedynak P, Cesaro P, Palfi S, Nguyen JP. PMID: 21768914.
      View in: PubMed   Mentions: 11     Fields:    Translation:Humans
    174. Relapse severity and recovery in early pediatric multiple sclerosis. Mult Scler. 2012 Jul; 18(7):1008-12. Fay AJ, Mowry EM, Strober J, Waubant E. PMID: 22183939.
      View in: PubMed   Mentions: 10     Fields:    Translation:Humans
    175. Incidence of acquired CNS demyelinating syndromes in a multiethnic cohort of children. Neurology. 2011 Sep 20; 77(12):1143-8. Langer-Gould A, Zhang JL, Chung J, Yeung Y, Waubant E, Yao J. PMID: 21865580.
      View in: PubMed   Mentions: 45     Fields:    Translation:HumansPHPublic Health
    176. Consensus Guidelines for CSF and Blood Biobanking for CNS Biomarker Studies. Mult Scler Int. 2011; 2011:246412. Teunissen CE, Tumani H, Bennett JL, Berven FS, Brundin L, Comabella M, Franciotta D, Federiksen JL, Fleming JO, Furlan R, Hintzen RQ, Hughes SG, Jimenez CR, Johnson MH, Killestein J, Krasulova E, Kuhle J, Magnone MC, Petzold A, Rajda C, Rejdak K, Schmidt HK, van Pesch V, Waubant E, Wolf C, Deisenhammer F, Giovannoni G, Hemmer B. PMID: 22096631.
      View in: PubMed   Mentions:
    177. Common viruses associated with lower pediatric multiple sclerosis risk. Neurology. 2011 Jun 07; 76(23):1989-95. Waubant E, Mowry EM, Krupp L, Chitnis T, Yeh EA, Kuntz N, Ness J, Chabas D, Strober J, McDonald J, Belman A, Milazzo M, Gorman M, Weinstock-Guttman B, Rodriguez M, Oksenberg JR, James JA. PMID: 21646624.
      View in: PubMed   Mentions: 28     Fields:    Translation:Humans
    178. Pediatric multiple sclerosis. Neurol Clin. 2011 May; 29(2):481-505. Chitnis T, Krupp L, Yeh A, Rubin J, Kuntz N, Strober JB, Chabas D, Weinstock-Guttmann B, Ness J, Rodriguez M, Waubant E. PMID: 21439455.
      View in: PubMed   Mentions: 12     Fields:    Translation:Humans
    179. Preface: multiple sclerosis in the 21st century. Neurol Clin. 2011 May; 29(2):xiii-xiv. Waubant EL. PMID: 21439436.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    180. Switching multiple sclerosis patients with breakthrough disease to second-line therapy. PLoS One. 2011 Feb 03; 6(2):e16664. Castillo-Trivino T, Mowry EM, Gajofatto A, Chabas D, Crabtree-Hartman E, Cree BA, Goodin DS, Green AJ, Okuda DT, Pelletier D, Zamvil SS, Vittinghoff E, Waubant E. PMID: 21304907.
      View in: PubMed   Mentions: 23     Fields:    Translation:Humans
    181. Diagnostic criteria for multiple sclerosis: 2010 revisions to the McDonald criteria. Ann Neurol. 2011 Feb; 69(2):292-302. Polman CH, Reingold SC, Banwell B, Clanet M, Cohen JA, Filippi M, Fujihara K, Havrdova E, Hutchinson M, Kappos L, Lublin FD, Montalban X, O'Connor P, Sandberg-Wollheim M, Thompson AJ, Waubant E, Weinshenker B, Wolinsky JS. PMID: 21387374.
      View in: PubMed   Mentions: 1887     Fields:    Translation:Humans
    182. Asymptomatic spinal cord lesions predict disease progression in radiologically isolated syndrome. Neurology. 2011 Feb 22; 76(8):686-92. Okuda DT, Mowry EM, Cree BA, Crabtree EC, Goodin DS, Waubant E, Pelletier D. PMID: 21270417.
      View in: PubMed   Mentions: 41     Fields:    Translation:Humans
    183. Vitamin D status and antibody levels to common viruses in pediatric-onset multiple sclerosis. Mult Scler. 2011 Jun; 17(6):666-71. Mowry EM, James JA, Krupp LB, Waubant E. PMID: 21212086.
      View in: PubMed   Mentions: 8     Fields:    Translation:HumansCells
    184. Multiple sclerosis therapies in pediatric patients with refractory multiple sclerosis. Arch Neurol. 2011 Apr; 68(4):437-44. Yeh EA, Waubant E, Krupp LB, Ness J, Chitnis T, Kuntz N, Ramanathan M, Belman A, Chabas D, Gorman MP, Rodriguez M, Rinker JR, Weinstock-Guttman B. PMID: 21149803.
      View in: PubMed   Mentions: 18     Fields:    Translation:Humans
    185. Pediatric multiple sclerosis. Continuum (Minneap Minn). 2010 Oct; 16(5 Multiple Sclerosis):181-92. Mowry EM, Waubant E. PMID: 22810605.
      View in: PubMed   Mentions:    Fields:    
    186. Health-related quality of life is reduced in pediatric multiple sclerosis. Pediatr Neurol. 2010 Aug; 43(2):97-102. Mowry EM, Julian LJ, Im-Wang S, Chabas D, Galvin AJ, Strober JB, Waubant E. PMID: 20610119.
      View in: PubMed   Mentions: 5     Fields:    Translation:Humans
    187. MS and the B cell controversy. Biochim Biophys Acta. 2011 Feb; 1812(2):231-8. Cross AH, Waubant E. PMID: 20674743.
      View in: PubMed   Mentions: 13     Fields:    Translation:HumansCells
    188. Vitamin D status is associated with relapse rate in pediatric-onset multiple sclerosis. Ann Neurol. 2010 May; 67(5):618-24. Mowry EM, Krupp LB, Milazzo M, Chabas D, Strober JB, Belman AL, McDonald JC, Oksenberg JR, Bacchetti P, Waubant E. PMID: 20437559.
      View in: PubMed   Mentions: 89     Fields:    Translation:Humans
    189. Abnormal B-cell cytokine responses a trigger of T-cell-mediated disease in MS? Ann Neurol. 2010 Apr; 67(4):452-61. Bar-Or A, Fawaz L, Fan B, Darlington PJ, Rieger A, Ghorayeb C, Calabresi PA, Waubant E, Hauser SL, Zhang J, Smith CH. PMID: 20437580.
      View in: PubMed   Mentions: 125     Fields:    Translation:HumansCellsCTClinical Trials
    190. Treatment of multiple sclerosis in children and adolescents. Expert Opin Pharmacother. 2010 Mar; 11(4):505-20. Kuntz NL, Chabas D, Weinstock-Guttman B, Chitnis T, Yeh EA, Krupp L, Ness J, Rodriguez M, Waubant E. PMID: 20163265.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    191. Younger children with MS have a distinct CSF inflammatory profile at disease onset. Neurology. 2010 Feb 02; 74(5):399-405. Chabas D, Ness J, Belman A, Yeh EA, Kuntz N, Gorman MP, Strober JB, De Kouchkovsky I, McCulloch C, Chitnis T, Rodriguez M, Weinstock-Guttman B, Krupp LB, Waubant E. PMID: 20124205.
      View in: PubMed   Mentions: 24     Fields:    Translation:Humans
    192. Does race matter for multiple sclerosis? Neurology. 2010 Feb 16; 74(7):532-3. Cree B, Waubant E. PMID: 20089941.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    193. Pediatric multiple sclerosis. Nat Rev Neurol. 2009 Nov; 5(11):621-31. Yeh EA, Chitnis T, Krupp L, Ness J, Chabas D, Kuntz N, Waubant E. PMID: 19826402.
      View in: PubMed   Mentions: 28     Fields:    Translation:HumansCells
    194. Rituximab in patients with primary progressive multiple sclerosis: results of a randomized double-blind placebo-controlled multicenter trial. Ann Neurol. 2009 Oct; 66(4):460-71. Hawker K, O'Connor P, Freedman MS, Calabresi PA, Antel J, Simon J, Hauser S, Waubant E, Vollmer T, Panitch H, Zhang J, Chin P, Smith CH. PMID: 19847908.
      View in: PubMed   Mentions: 207     Fields:    Translation:HumansCTClinical Trials
    195. Difference in disease burden and activity in pediatric patients on brain magnetic resonance imaging at time of multiple sclerosis onset vs adults. Arch Neurol. 2009 Aug; 66(8):967-71. Waubant E, Chabas D, Okuda DT, Glenn O, Mowry E, Henry RG, Strober JB, Soares B, Wintermark M, Pelletier D. PMID: 19667217.
      View in: PubMed   Mentions: 31     Fields:    Translation:Humans
    196. Absence of neuromyelitis optica IgG antibody in an active relapsing-remitting multiple sclerosis population. J Neuroophthalmol. 2009 Jun; 29(2):104-6. Smith CH, Waubant E, Langer-Gould A. PMID: 19491632.
      View in: PubMed   Mentions: 3     Fields:    Translation:HumansCTClinical Trials
    197. Quality of life in multiple sclerosis is associated with lesion burden and brain volume measures. Neurology. 2009 May 19; 72(20):1760-5. Mowry EM, Beheshtian A, Waubant E, Goodin DS, Cree BA, Qualley P, Lincoln R, George MF, Gomez R, Hauser SL, Okuda DT, Pelletier D. PMID: 19451531.
      View in: PubMed   Mentions: 19     Fields:    Translation:Humans
    198. Pediatric multiple sclerosis. Curr Treat Options Neurol. 2009 May; 11(3):203-10. Waubant E, Chabas D. PMID: 19364455.
      View in: PubMed   Mentions:
    199. Clinical predictors of early second event in patients with clinically isolated syndrome. J Neurol. 2009 Jul; 256(7):1061-6. Mowry EM, Pesic M, Grimes B, Deen SR, Bacchetti P, Waubant E. PMID: 19252775.
      View in: PubMed   Mentions: 14     Fields:    Translation:Humans
    200. Demyelinating events in early multiple sclerosis have inherent severity and recovery. Neurology. 2009 Feb 17; 72(7):602-8. Mowry EM, Pesic M, Grimes B, Deen S, Bacchetti P, Waubant E. PMID: 19221292.
      View in: PubMed   Mentions: 19     Fields:    Translation:HumansCells
    201. Incidental MRI anomalies suggestive of multiple sclerosis: the radiologically isolated syndrome. Neurology. 2009 Mar 03; 72(9):800-5. Okuda DT, Mowry EM, Beheshtian A, Waubant E, Baranzini SE, Goodin DS, Hauser SL, Pelletier D. PMID: 19073949.
      View in: PubMed   Mentions: 87     Fields:    Translation:Humans
    202. The onset location of multiple sclerosis predicts the location of subsequent relapses. J Neurol Neurosurg Psychiatry. 2009 Apr; 80(4):400-3. Mowry EM, Deen S, Malikova I, Pelletier J, Bacchetti P, Waubant E. PMID: 19066192.
      View in: PubMed   Mentions: 12     Fields:    Translation:Humans
    203. Genotype-Phenotype correlations in multiple sclerosis: HLA genes influence disease severity inferred by 1HMR spectroscopy and MRI measures. Brain. 2009 Jan; 132(Pt 1):250-9. Okuda DT, Srinivasan R, Oksenberg JR, Goodin DS, Baranzini SE, Beheshtian A, Waubant E, Zamvil SS, Leppert D, Qualley P, Lincoln R, Gomez R, Caillier S, George M, Wang J, Nelson SJ, Cree BA, Hauser SL, Pelletier D. PMID: 19022862.
      View in: PubMed   Mentions: 39     Fields:    Translation:Humans
    204. Genome-wide association analysis of susceptibility and clinical phenotype in multiple sclerosis. Hum Mol Genet. 2009 Feb 15; 18(4):767-78. Baranzini SE, Wang J, Gibson RA, Galwey N, Naegelin Y, Barkhof F, Radue EW, Lindberg RL, Uitdehaag BM, Johnson MR, Angelakopoulou A, Hall L, Richardson JC, Prinjha RK, Gass A, Geurts JJ, Kragt J, Sombekke M, Vrenken H, Qualley P, Lincoln RR, Gomez R, Caillier SJ, George MF, Mousavi H, Guerrero R, Okuda DT, Cree BA, Green AJ, Waubant E, Goodin DS, Pelletier D, Matthews PM, Hauser SL, Kappos L, Polman CH, Oksenberg JR. PMID: 19010793.
      View in: PubMed   Mentions: 162     Fields:    Translation:Humans
    205. Switching first-line disease-modifying therapy after failure: impact on the course of relapsing-remitting multiple sclerosis. Mult Scler. 2009 Jan; 15(1):50-8. Gajofatto A, Bacchetti P, Grimes B, High A, Waubant E. PMID: 18922831.
      View in: PubMed   Mentions: 26     Fields:    Translation:HumansPHPublic HealthCTClinical Trials
    206. Vanishing MS T2-bright lesions before puberty: a distinct MRI phenotype? Neurology. 2008 Sep 30; 71(14):1090-3. Chabas D, Castillo-Trivino T, Mowry EM, Strober JB, Glenn OA, Waubant E. PMID: 18824673.
      View in: PubMed   Mentions: 23     Fields:    Translation:HumansCells
    207. Pediatric multiple sclerosis. Curr Neurol Neurosci Rep. 2008 Sep; 8(5):434-41. Chabas D, Strober J, Waubant E. PMID: 18713581.
      View in: PubMed   Mentions: 7     Fields:    Translation:Humans
    208. Spotlight on anti-CD20. Int MS J. 2008 Mar; 15(1):19-25. Waubant E. PMID: 18713565.
      View in: PubMed   Mentions: 9     Fields:    Translation:HumansCells
    209. Rituximab in relapsing-remitting multiple sclerosis: a 72-week, open-label, phase I trial. Ann Neurol. 2008 Mar; 63(3):395-400. Bar-Or A, Calabresi PA, Arnold D, Arnlod D, Markowitz C, Shafer S, Kasper LH, Waubant E, Gazda S, Fox RJ, Panzara M, Sarkar N, Agarwal S, Smith CH. PMID: 18383069.
      View in: PubMed   Mentions: 133     Fields:    Translation:HumansCellsCTClinical Trials
    210. B-cell depletion with rituximab in relapsing-remitting multiple sclerosis. N Engl J Med. 2008 Feb 14; 358(7):676-88. Hauser SL, Waubant E, Arnold DL, Vollmer T, Antel J, Fox RJ, Bar-Or A, Panzara M, Sarkar N, Agarwal S, Langer-Gould A, Smith CH. PMID: 18272891.
      View in: PubMed   Mentions: 605     Fields:    Translation:HumansCellsCTClinical Trials
    211. Predictors of the location of multiple sclerosis relapse. J Neurol Neurosurg Psychiatry. 2008 Oct; 79(10):1190-3. Deen S, Bacchetti P, High A, Waubant E. PMID: 18223021.
      View in: PubMed   Mentions: 5     Fields:    Translation:Humans
    212. Clinical features and viral serologies in children with multiple sclerosis: a multinational observational study. Lancet Neurol. 2007 Sep; 6(9):773-81. Banwell B, Krupp L, Kennedy J, Tellier R, Tenembaum S, Ness J, Belman A, Boiko A, Bykova O, Waubant E, Mah JK, Stoian C, Kremenchutzky M, Bardini MR, Ruggieri M, Rensel M, Hahn J, Weinstock-Guttman B, Yeh EA, Farrell K, Freedman M, Iivanainen M, Sevon M, Bhan V, Dilenge ME, Stephens D, Bar-Or A. PMID: 17689148.
      View in: PubMed   Mentions: 78     Fields:    Translation:HumansCells
    213. Identification of short-term pharmacodynamic effects of interferon-beta-1a in multiple sclerosis subjects with broad- based phenotypic profiling. J Neuroimmunol. 2007 Aug; 188(1-2):103-16. Kantor AB, Deng J, Waubant E, Lin H, Becker CH, Lacy JR, Perrone AM, Bennett D, Goelz SE. PMID: 17614141.
      View in: PubMed   Mentions: 7     Fields:    Translation:HumansCellsCTClinical Trials
    214. Emerging therapies for MS. Rev Neurol (Paris). 2007 Jun; 163(6-7):688-96. Waubant E. PMID: 17607191.
      View in: PubMed   Mentions: 1     Fields:    Translation:HumansAnimalsCells
    215. Challenges in the classification of pediatric multiple sclerosis and future directions. Neurology. 2007 Apr 17; 68(16 Suppl 2):S70-4. Belman AL, Chitnis T, Renoux C, Waubant E. PMID: 17438242.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    216. Are initial demyelinating event recovery and time to second event under differential control? Neurology. 2006 Sep 12; 67(5):809-13. West T, Wyatt M, High A, Bostrom A, Waubant E. PMID: 16966542.
      View in: PubMed   Mentions: 12     Fields:    Translation:Humans
    217. Pediatric multiple sclerosis. NeuroRx. 2006 Apr; 3(2):264-75. Chabas D, Green AJ, Waubant E. PMID: 16554264.
      View in: PubMed   Mentions: 9     Fields:    Translation:Humans
    218. Biomarkers indicative of blood-brain barrier disruption in multiple sclerosis. Dis Markers. 2006; 22(4):235-44. Waubant E. PMID: 17124345.
      View in: PubMed   Mentions: 27     Fields:    Translation:Humans
    219. Acute pathological laughter. Mov Disord. 2005 Oct; 20(10):1389-90. Okuda DT, Chyung AS, Chin CT, Waubant E. PMID: 16007658.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    220. Interferon beta babies. Neurology. 2005 Sep 27; 65(6):788-9. Waubant E, Sadovnick AD. PMID: 16186513.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    221. An open label study of the effects of rituximab in neuromyelitis optica. Neurology. 2005 Apr 12; 64(7):1270-2. Cree BA, Lamb S, Morgan K, Chen A, Waubant E, Genain C. PMID: 15824362.
      View in: PubMed   Mentions: 140     Fields:    Translation:HumansCellsPHPublic HealthCTClinical Trials
    222. Multiple sclerosis tremor and the Stewart-Holmes manoeuvre. Mov Disord. 2003 Aug; 18(8):948-52. Waubant E, Tezenas du Montcel S, Jedynak C, Obadia M, Hosseini H, Damier P, Lubetzki C, Agid Y, Degos JD. PMID: 12889088.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    223. Clinical characteristics of responders to interferon therapy for relapsing MS. Neurology. 2003 Jul 22; 61(2):184-9. Waubant E, Vukusic S, Gignoux L, Dubief FD, Achiti I, Blanc S, Renoux C, Confavreux C. PMID: 12874396.
      View in: PubMed   Mentions: 22     Fields:    Translation:Humans
    224. Emerging disease modifying therapies for multiple sclerosis. Expert Opin Emerg Drugs. 2003 May; 8(1):145-61. Waubant E. PMID: 14610918.
      View in: PubMed   Mentions: 1     Fields:    Translation:HumansAnimals
    225. IFNbeta lowers MMP-9/TIMP-1 ratio, which predicts new enhancing lesions in patients with SPMS. Neurology. 2003 Jan 14; 60(1):52-7. Waubant E, Goodkin D, Bostrom A, Bacchetti P, Hietpas J, Lindberg R, Leppert D. PMID: 12525717.
      View in: PubMed   Mentions: 19     Fields:    Translation:HumansCTClinical Trials
    226. Interferon beta-1a in children with multiple sclerosis is well tolerated. Neuropediatrics. 2001 Aug; 32(4):211-3. Waubant E, Hietpas J, Stewart T, Dyme Z, Herbert J, Lacy J, Miller C, Rensel M, Schwid S, Goodkin D. PMID: 11571702.
      View in: PubMed   Mentions: 22     Fields:    Translation:Humans
    227. IFN-beta1a may increase serum levels of TIMP-1 in patients with relapsing-remitting multiple sclerosis. J Interferon Cytokine Res. 2001 Mar; 21(3):181-5. Waubant E, Gee L, Miller K, Stabler G, Goodkin D. PMID: 11331041.
      View in: PubMed   Mentions: 3     Fields:    Translation:HumansCTClinical Trials
    228. Relationship between serum levels of IL-10, MRI activity and interferon beta-1a therapy in patients with relapsing remitting MS. J Neuroimmunol. 2001 Jan 01; 112(1-2):139-45. Waubant E, Gee L, Bacchetti P, Sloan R, Cotleur A, Rudick R, Goodkin D. PMID: 11108942.
      View in: PubMed   Mentions: 9     Fields:    Translation:Humans
    229. 1H MRSI comparison of white matter and lesions in primary progressive and relapsing-remitting MS. Mult Scler. 2000 Jun; 6(3):148-55. Suhy J, Rooney WD, Goodkin DE, Capizzano AA, Soher BJ, Maudsley AA, Waubant E, Andersson PB, Weiner MW. PMID: 10871825.
      View in: PubMed   Mentions: 28     Fields:    Translation:Humans
    230. Magnetization transfer ratio in new MS lesions before and during therapy with IFNbeta-1a. Neurology. 2000 May 09; 54(9):1741-5. Kita M, Goodkin DE, Bacchetti P, Waubant E, Nelson SJ, Majumdar S. PMID: 10802778.
      View in: PubMed   Mentions: 5     Fields:    Translation:Humans
    231. A phase I trial of solubilized DR2:MBP84-102 (AG284) in multiple sclerosis. Neurology. 2000 Apr 11; 54(7):1414-20. Goodkin DE, Shulman M, Winkelhake J, Waubant E, Andersson P, Stewart T, Nelson S, Fischbein N, Coyle PK, Frohman E, Jacobs L, Holcenberg J, Lee M, Mocci S. PMID: 10751249.
      View in: PubMed   Mentions: 9     Fields:    Translation:HumansCellsCTClinical Trials
    232. Methodological problems in evaluating efficacy of a treatment in multiple sclerosis. Pathol Biol (Paris). 2000 Mar; 48(2):104-13. Waubant E, Goodkin D. PMID: 10815286.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    233. Serum MMP-9 and TIMP-1 levels are related to MRI activity in relapsing multiple sclerosis. Neurology. 1999 Oct 22; 53(7):1397-401. Waubant E, Goodkin DE, Gee L, Bacchetti P, Sloan R, Stewart T, Andersson PB, Stabler G, Miller K. PMID: 10534241.
      View in: PubMed   Mentions: 29     Fields:    Translation:Humans
    234. A pilot study of MRI activity before and during interferon beta-1a therapy. Neurology. 1999 Sep 11; 53(4):874-6. Waubant E, Goodkin DE, Sloan R, Andersson PB. PMID: 10489060.
      View in: PubMed   Mentions: 6     Fields:    Translation:Humans
    235. Multiple sclerosis that is progressive from the time of onset: clinical characteristics and progression of disability. Arch Neurol. 1999 Sep; 56(9):1138-42. Andersson PB, Waubant E, Gee L, Goodkin DE. PMID: 10488816.
      View in: PubMed   Mentions: 13     Fields:    Translation:Humans
    236. [How phase III therapeutic trials in multiple sclerosis should be evaluated: advances and challenges]. Rev Neurol (Paris). 1999; 155 Suppl 2:S7-12. Waubant E, Goodkin D. PMID: 10367319.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    237. [Effect of weekly intramuscular interferon beta-1a on MRI lesions in patients with relapsing multiple sclerosis]. Rev Neurol (Paris). 1999; 155 Suppl 2:S20-3. Waubant E, Sloan R, Andersson PB, Goodkin D. PMID: 10367321.
      View in: PubMed   Mentions:    Fields:    Translation:HumansCTClinical Trials
    238. A serial study of new MS lesions and the white matter from which they arise. Neurology. 1998 Dec; 51(6):1689-97. Goodkin DE, Rooney WD, Sloan R, Bacchetti P, Gee L, Vermathen M, Waubant E, Abundo M, Majumdar S, Nelson S, Weiner MW. PMID: 9855524.
      View in: PubMed   Mentions: 33     Fields:    Translation:HumansCells
    239. Cervical cord glioma in an HIV-positive patient. Eur Neurol. 1998; 39(1):58-60. Waubant E, Delisle MB, Bonafé A, Gray F, Clanet M. PMID: 9476726.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    240. How should we proceed with disease-modifying treatments for multiple sclerosis? Lancet. 1997 Mar 01; 349(9052):586-7. Andersson PB, Waubant E, Goodkin DE. PMID: 9057726.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    241. T cell gelatinases mediate basement membrane transmigration in vitro. J Immunol. 1995 May 01; 154(9):4379-89. Leppert D, Waubant E, Galardy R, Bunnett NW, Hauser SL. PMID: 7722295.
      View in: PubMed   Mentions: 70     Fields:    Translation:HumansCells